Search results

Found 2,264 pages
AUTHOR: Lynne Taylor

14 Jan 2015:

Top therapy investment areas for 2015

Oncology, cardiovascular, autoimmune/anti-inflammatories and infectious diseases will be the top therapeutic areas for investment in 2015, says new research. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/top_therapy_investment_areas_for_2015_970867

24 Aug 2010:

New breaches of ABPI Code

ProStrakan, Cephalon UK and GlaxoSmithKline Consumer Healthcare have this month been named in advertisements for breaches of the Association of the British Pharmaceutical Industry’s Code of Practice. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/new_breaches_of_abpi_code_982554

6 Dec 2012:

IMI: seven new projects to boost drug development

Europe's Innovative Medicines Initiative (IMI) has launched seven new projects, with a total budget of more than 237 million euros, aimed at accelerating the development of safer and more effective drugs. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/imi_seven_new_projects_to_boost_drug_development_976086

12 Feb 2014:

NICE calls for "much wider" use of statins

In new draft guidance, the National Institute for Health and Care Excellence (NICE) is recommending that people with a 10% risk of developing cardiovascular disease (CVD) within 10 years should be offered statin therapy. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/nice_calls_for_much_wider_use_of_statins_1001524

4 Dec 2008:

Govt to consult on modernising NHS science careers

The government has launched a consultation on its plans to modernise scientific careers in the National Health Service (NHS) throughout the UK, by transforming the training and career pathways of the healthcare scientist (HCS) workforce. - News -

by Lynne Taylor

https://www.pharmatimes.com/news/govt_to_consult_on_modernising_nhs_science_careers_986246

7 Oct 2008:

Norgine slams ABPI over PPRS

European specialty pharmaceutical company Norgine has resigned from the Association of the British Pharmaceutical Industry (ABPI), claiming that the group no longer represents the interests of smaller, specialist firms. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/norgine_slams_abpi_over_pprs_986659

6 Nov 2014:

Psoriasis drugs market set for robust growth

Sales in major markets of drugs to treat psoriasis are set for robust growth over the next decade, increasing from $6.6 billion in 2013 to $10.7 billion in 2023, according to new forecasts. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/psoriasis_drugs_market_set_for_robust_growth_1002733

16 Sep 2013:

EMA reshapes for the future

The European Medicines Agency (EMA) has announced details of its new organisational structure, with four new Divisions at its core. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/ema_reshapes_for_the_future_1005687

10 Sep 2013:

UK standards for homecare services launched

The Department of Health Homecare Strategy Board and the Royal Pharmaceutical Society have published new professional standards for homecare services, to ensure patient safety and the effective management of medicines delivered via the homecare route

by Lynne Taylor

https://www.pharmatimes.com/news/uk_standards_for_homecare_services_launched_1005665

24 Jul 2008:

MPs to probe patient safety

The House of Commons Health Select Committee has announced that, during the next session of Parliament, it will undertake an inquiry into patient safety. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/mps_to_probe_patient_safety_988219